Rosetta Genomics Stock Technical Analysis
| ROSGQ Stock | USD 0.0001 0.0001 50.00% |
As of the 28th of February, Rosetta Genomics holds the Coefficient Of Variation of 1827.74, risk adjusted performance of 0.0513, and Variance of 191.72. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rosetta Genomics, as well as the relationship between them.
Rosetta Genomics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Rosetta, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to RosettaRosetta |
Rosetta Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rosetta Genomics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rosetta Genomics.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in Rosetta Genomics on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Rosetta Genomics or generate 0.0% return on investment in Rosetta Genomics over 90 days. Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide More
Rosetta Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rosetta Genomics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rosetta Genomics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0482 | |||
| Maximum Drawdown | 150.0 |
Rosetta Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rosetta Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rosetta Genomics' standard deviation. In reality, there are many statistical measures that can use Rosetta Genomics historical prices to predict the future Rosetta Genomics' volatility.| Risk Adjusted Performance | 0.0513 | |||
| Jensen Alpha | 1.0 | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.23) |
Rosetta Genomics February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0513 | |||
| Market Risk Adjusted Performance | (0.22) | |||
| Mean Deviation | 3.01 | |||
| Coefficient Of Variation | 1827.74 | |||
| Standard Deviation | 13.85 | |||
| Variance | 191.72 | |||
| Information Ratio | 0.0482 | |||
| Jensen Alpha | 1.0 | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.23) | |||
| Maximum Drawdown | 150.0 | |||
| Skewness | 5.06 | |||
| Kurtosis | 44.43 |
Rosetta Genomics Backtested Returns
Rosetta Genomics appears to be out of control, given 3 months investment horizon. Rosetta Genomics maintains Sharpe Ratio (i.e., Efficiency) of 0.0564, which implies the firm had a 0.0564 % return per unit of risk over the last 3 months. By analyzing Rosetta Genomics' technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please evaluate Rosetta Genomics' Variance of 191.72, risk adjusted performance of 0.0513, and Coefficient Of Variation of 1827.74 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Rosetta Genomics holds a performance score of 4. The company holds a Beta of -3.21, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Rosetta Genomics are expected to decrease by larger amounts. On the other hand, during market turmoil, Rosetta Genomics is expected to outperform it. Please check Rosetta Genomics' total risk alpha and day typical price , to make a quick decision on whether Rosetta Genomics' historical price patterns will revert.
Auto-correlation | -1 |
Near perfect reversele predictability
Rosetta Genomics has near perfect reversele predictability. Overlapping area represents the amount of predictability between Rosetta Genomics time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rosetta Genomics price movement. The serial correlation of -1.0 indicates that 100.0% of current Rosetta Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -1.0 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Rosetta Genomics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Rosetta Genomics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Rosetta Genomics across different markets.
About Rosetta Genomics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Rosetta Genomics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Rosetta Genomics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Rosetta Genomics price pattern first instead of the macroeconomic environment surrounding Rosetta Genomics. By analyzing Rosetta Genomics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Rosetta Genomics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Rosetta Genomics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Rosetta Genomics February 28, 2026 Technical Indicators
Most technical analysis of Rosetta help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Rosetta from various momentum indicators to cycle indicators. When you analyze Rosetta charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0513 | |||
| Market Risk Adjusted Performance | (0.22) | |||
| Mean Deviation | 3.01 | |||
| Coefficient Of Variation | 1827.74 | |||
| Standard Deviation | 13.85 | |||
| Variance | 191.72 | |||
| Information Ratio | 0.0482 | |||
| Jensen Alpha | 1.0 | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.23) | |||
| Maximum Drawdown | 150.0 | |||
| Skewness | 5.06 | |||
| Kurtosis | 44.43 |
Rosetta Genomics February 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Rosetta stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.50 | ||
| Day Median Price | 0.00 | ||
| Day Typical Price | 0.00 | ||
| Price Action Indicator | 0.00 |
Additional Tools for Rosetta Pink Sheet Analysis
When running Rosetta Genomics' price analysis, check to measure Rosetta Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rosetta Genomics is operating at the current time. Most of Rosetta Genomics' value examination focuses on studying past and present price action to predict the probability of Rosetta Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rosetta Genomics' price. Additionally, you may evaluate how the addition of Rosetta Genomics to your portfolios can decrease your overall portfolio volatility.